Targeting One Enzyme May Prevent Obesity-Induced Heart Disease, Study Suggests
Atrial fibrillation, or A-fib, is an irregular heart rhythm that increases a person's risk of stroke, heart failure and even ...
Science Daily2h
Study shows anti-clotting drug reduced bleeding events in patients with atrial fibrillation
Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study. The trial ...
Anti-clotting drug significantly reduces bleeding events in patients with atrial fibrillation, clinical trial shows
Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, but many may discontinue them or never receive a prescription due to ...
News Medical on MSN18h
New Factor XI inhibitor shows superior safety in treating atrial fibrillation
Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, but many may discontinue them or never receive a prescription due to ...
katc9d
New technology revolutionizes AFib treatment at Our Lady of Lourdes
Our Lady of Lourdes Regional Medical Center is embracing cutting-edge technology to transform how heart conditions are ...
UVA Today2h
Unlocking Secrets of the Heart: Simple Scan Could Identify Patients at Risk
That test could help identify patients at greatest risk for potentially deadly cardiac problems such as coronary artery disease, atrial fibrillation (irregular heartbeat) and heart failure, and ...
The American Journal of Managed Care23h
Abelacimab, a “Game Changer” for High-Risk Patients With AFib: Dr Ruff and Dr Bloomfield Elaborate on Latest Data From AZALEA-TIMI 71 Trial
Clinically significant reductions in bleeding underscore abelacimab’s strong potential to address an unmet need for patients ...